Published in Shock on February 01, 1999
Formula diet alters small intestine morphology, microbial abundance and reduces VE-cadherin and IL-10 expression in neonatal porcine model. BMC Gastroenterol (2016) 1.41
Targeting polyamines and inflammation for cancer prevention. Recent Results Cancer Res (2011) 1.06
Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity. Inflamm Bowel Dis (2010) 0.89
Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention. Amino Acids (2013) 0.88
activated polyamine catabolism in acute pancreatitis: alpha-methylated polyamine analogues prevent trypsinogen activation and pancreatitis-associated mortality. Am J Pathol (2006) 0.82
Chemoprevention of gastrointestinal cancer: the reality and the dream. Gut Liver (2013) 0.81
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System. Cell Metab (2017) 0.75
Spermine and endothelial damage during endotoxemia. Inflammation (2008) 0.75
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest (1999) 2.55
Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis (1997) 2.39
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology (1992) 2.23
Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther (2013) 2.20
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax (2001) 1.94
Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol (1995) 1.94
Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem (1996) 1.85
Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods (1987) 1.85
Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol (1993) 1.74
Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int (2007) 1.64
Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res (1991) 1.63
Randomized clinical trial of the effect of gum chewing on postoperative ileus and inflammation in colorectal surgery. Br J Surg (2014) 1.59
Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol (1994) 1.57
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol (1997) 1.56
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol (1995) 1.56
Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol (1988) 1.51
Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol (2000) 1.51
Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology (1992) 1.49
Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) (1999) 1.49
Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis (1998) 1.44
The prevalence of Helicobacter pylori serum antibodies in children with recurrent abdominal pain. Eur J Pediatr (1992) 1.44
Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr (1999) 1.42
Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med (1989) 1.39
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. Ann Rheum Dis (2002) 1.38
Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation (1999) 1.38
IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro. J Immunol (1990) 1.38
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene (2012) 1.37
Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet (1991) 1.35
Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation (2000) 1.30
Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. J Immunol (1999) 1.30
Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med (1997) 1.29
Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol (1998) 1.28
Lipopolysaccharide toxicity-regulating proteins in bacteremia. J Infect Dis (1995) 1.27
Tumor necrosis factor: function, release and clearance. Crit Rev Immunol (1996) 1.25
Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein. J Immunol (1994) 1.24
TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J Immunol (1996) 1.24
Slow release of soluble TNF receptors by monocytes in vitro. J Immunol (1994) 1.24
Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol (1996) 1.23
Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord (2001) 1.22
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.22
LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J Immunol (1993) 1.21
Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol (2000) 1.20
Evidence for endocytosis of E-selectin in human endothelial cells. Eur J Immunol (1992) 1.17
Prevention of postoperative complications in jaundiced rats. Internal biliary drainage versus oral lactulose. Ann Surg (1990) 1.16
Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev (1999) 1.14
Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J Immunol (1997) 1.14
Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology (1990) 1.14
LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest (2001) 1.14
Monoclonal antibody to endotoxin core protects mice from Escherichia coli sepsis by a mechanism independent of tumor necrosis factor and interleukin-6. J Infect Dis (1990) 1.13
Induction of an activation antigen on human endothelial cells in vitro. Eur J Immunol (1989) 1.13
Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut (2007) 1.13
Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur J Immunol (1998) 1.11
Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. Eur J Pediatr (1993) 1.11
Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature (1985) 1.11
Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med (1998) 1.11
Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils. Am J Respir Cell Mol Biol (2001) 1.10
Computer aided design and evaluation of limiting and serial dilution experiments. Int J Biomed Comput (1988) 1.10
Metabolic characteristics of in vitro cultured human chondrocytes in relation to the histopathologic grade of osteoarthritis. Clin Orthop Relat Res (1989) 1.10
Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol (1993) 1.08
Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood (1994) 1.07
Abnormal small bowel permeability and duodenitis in recurrent abdominal pain. Arch Dis Child (1990) 1.05
Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic/hypovolemic shock in the baboon. Am J Pathol (1991) 1.05
Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine (1994) 1.05
Long-term growth of children with congenital heart disease: a retrospective study. Acta Paediatr (1998) 1.05
The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect Immun (1999) 1.05
Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.04
Mobilization of haemopoietic stem cells (CFU) into the peripheral blood of the mouse; effects of endotoxin and other compounds. Cell Tissue Kinet (1972) 1.04
Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1. J Immunol (1990) 1.04
Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand J Immunol (1992) 1.04
Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol (1999) 1.03
Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur J Immunol (1988) 1.02
Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens. J Exp Med (1986) 1.02
Gastroesophageal reflux in children with recurrent abdominal pain. Acta Paediatr (1992) 1.02
Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model. Scand J Immunol (1990) 1.01
Apoptosis and chemokine induction after renal ischemia-reperfusion. Transplantation (2001) 1.01
Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis (1998) 1.00
Adhesion of polymorphonuclear cells to human endothelial cells. Adhesion-molecule-dependent, and Fc receptor-mediated adhesion-molecule-independent mechanisms. Clin Exp Immunol (1990) 1.00
Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria. Eur J Immunol (1998) 1.00
Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells. J Immunol (1985) 1.00
Lactulose-rhamnose intestinal permeability in children with cystic fibrosis. J Pediatr Gastroenterol Nutr (1987) 0.99
Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab (2004) 0.99
The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res (1991) 0.98
Spontaneous and stimulated release of tumor necrosis factor-alpha (TNF) from blood monocytes of miners with coal workers' pneumoconiosis. Am Rev Respir Dis (1988) 0.98
The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects. Int J Obes Relat Metab Disord (2002) 0.97
Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res (2001) 0.97
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood (1997) 0.97
Characterization of two monoclonal antibodies directed against an adhesion molecule on human endothelial cells. Transplant Proc (1990) 0.97
Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression. J Exp Med (1987) 0.97
Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis (1995) 0.97
Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol (1994) 0.96
Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism (1990) 0.96
Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology (1989) 0.95
Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae. J Antimicrob Chemother (2000) 0.94
Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol (1989) 0.94
Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis (1992) 0.94